GlassScriptPhysician profile
Laura Keiler Topper
NPI 1649306655
$1,812.14
in general payments reported to CMS, 2019-2025
27 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.34 · 2022: $246 · 2023: $568 · 2024: $549 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $318.99 | 2022-2025 | |
| Atricure, INC. | $189.93 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.85 | 2023-2025 | Lifevest |
| Abbott Laboratories | $160.87 | 2021-2024 | Aveir |
| Janssen Pharmaceuticals, INC | $126.93 | 2021-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $94.31 | 2024 | |
| Pfizer INC. | $92.72 | 2022-2025 | |
| Novo Nordisk INC | $74.41 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $73.24 | 2024-2025 | Opsumit, Uptravi |
| Corcept Therapeutics | $60.59 | 2024-2025 | Korlym |
| Boston Scientific Corporation | $58.39 | 2022-2023 | Bodyguardian |
| Neurelis, INC. | $44.22 | 2024-2025 | Valtoco |
| Merck Sharp & Dohme LLC | $43.25 | 2023 | Verquvo |
| Cvrx, INC. | $37.15 | 2024 | Barostim Neo System |
| Harmony Biosciences LLC | $28.10 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $27.33 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $26.65 | 2021-2025 | Selectsecure |
| Alnylam Pharmaceuticals INC. | $26.57 | 2022 | |
| Irhythm Technologies, INC. | $24.10 | 2024 | Zio Monitor, Zio Xt Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.35 | 2023 | Jardiance |
| Glaxosmithkline, LLC. | $21.97 | 2025 | Shingrix |
| Astrazeneca Pharmaceuticals LP | $18.91 | 2025 | Farxiga |
| Kestra Medical Technology Services, INC. | $18.73 | 2025 | Assure Wcd |
| Medicomp INC | $17.59 | 2025 | Telepatch Cardiac Monitor |
| Scpharmaceuticals INC. | $15.18 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $13.19 | 2023 | Eliquis |
| Aucta Pharmaceuticals, INC. | $9.62 | 2024 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Topper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.